Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
nextSource Announces Leading Talent Providers in the Keystone Recognition Program
-
IntelGenx Announces First Parkinson’s Disease Patients Dosed with Montelukast VersaFilm® in Phase 2 ‘MONTPARK’ Clinical Trial
-
BioRestorative Therapies Partners with Galen Patient Recruitment to Accelerate Completion of Enrollment in Phase 2 Trial of BRTX-100 in Chronic Lumbar Disc Disease
-
Inception Growth Acquisition Limited Announces Additional Contribution to Trust Account to Extend Business Combination Period
-
Watsco’s Earnings Call to Discuss First Quarter Results Scheduled on April 24, 2024
-
MariMed Announces First Quarter 2024 Earnings Date
-
XORTX Welcomes New Member to the Board of Directors
-
World Orphan Drug Alliance Expands to Japan & South Korea and the African Subcontinent
-
Intermap Drives Infrastructure Advancements in Greece and Malawi
-
Venus Concept Announces Israeli Regulatory Approval for Venus Bliss MAX
-
Form 8.3 - ABRDN European Logistics Income PLC
-
Restaurants Canada Show to Feature Opening Remarks by Ontario Premier Doug Ford
-
Verisk Pioneers New Approach to Catastrophe Risk with Release of Next Generation Models
-
SAB Biotherapeutics to Present at INNODIA Annual Meeting
-
Poolside upsizes and extends AI Cloud Services contract
-
Goliath Resources Limited Pre-Selected by Noble Capital Markets Inc. to Present at NobleCon20
-
Form 8.3 - UK Commercial Property REIT
-
Gilat Expanding into Additional IFC Market Segments After Receiving Over $3 Million in Orders from a Leading IFC Service Provider
-
Kraig Biocraft Laboratories Signs Landmark Agreement in Vietnam's Silk Production Capital
-
Samsung Bioepis Releases Second Quarter 2024 US Biosimilar Market Report
-
Principal Investigator from City of Hope National Medical Center Invited to Present Clinical Data from Marker Therapeutics APOLLO Study at 11th Global Summit on Hematologic Malignancies
-
Renalytix Announces Financing with Expected Size of up to $4 Million
-
G2 Goldfields Announces Graduation to the TSX
-
XORTX Announces Participation in Spring 2024 Investor Conferences
-
Akoustis Secures Design Win and Volume Orders for Wi-Fi 7 Solution with Tier-1 Enterprise Class OEM
-
Gritstone bio Presents Improvements to EDGE™ Platform at AACR 2024
-
Global Helium Corp. Announces Seismic Review Option Agreement With Industry Leader, North American Helium
-
Ascot Commences Ore Processing at the Premier Gold Project
-
Blue Water Industries Completes Sale of Certain Aggregates Operations to Martin Marietta
-
Breakthrough in Immune Cell Expansion: Pluri Granted U.S Patent for New Method
-
James River Granted Motion Ordering Fleming to Complete its Pending Acquisition of JRG Re
-
Pineapple Energy Encourages Shareholders to Vote FOR the Reverse Stock Split and Increase in Authorized Shares
-
Akoustis Secures Design Win and Volume Orders for Wi-Fi 7 Solution with Tier-1 Enterprise Class OEM
-
Graphjet Technology to Build New Agricultural Waste-to-Graphite Production Facility in Nevada
-
Idol World - Redefines Legendary Audition Gaming With NFT Integration And $TOME Meme Coin
-
Eyenovia Announces Updated Strategy and Corporate Priorities to Focus on Shareholder Value Generation and Immediate Commercial Opportunities
-
Standard Uranium Provides Exploration Activities Update on the Canary Project, Eastern Athabasca Basin
-
Kymera Therapeutics Announces Scientific Presentations at the American Association for Cancer Research 2024 Annual Meeting
-
TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy
-
CareCloud’s medSR division to Showcase Consultation and Implementation Services at Becker’s Annual Conference
-
Macerich Schedules First Quarter 2024 Earnings Release and Conference Call
-
Multitude SE - Managers' Transactions - Vella
-
Multitude SE - Managers' Transactions - Kabele
-
Multitude SE - Managers' Transactions - Stareika
-
Multitude SE - Managers' Transactions - Kajakas
-
NextCure and LCB Present Preclinical Data on B7-H4 Antibody Drug Conjugate at AACR 2024
-
Multitude SE - Managers' Transactions - Liigus
-
Multitude SE - Managers' Transactions - Kumpulainen
-
Multitude SE - Managers' Transactions - Egger
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Wincanton plc

